Literature DB >> 21576942

Proposal for a new grading of Moyamoya disease in adult patients.

M Czabanka1, P Peña-Tapia, G A Schubert, F L Heppner, P Martus, P Horn, P Schmiedek, P Vajkoczy.   

Abstract

BACKGROUND: Moyamoya disease (MMD) is graded based on digital subtraction angiography (DSA) with limited clinical applications. The aim was to identify clinically relevant parameters that may be used to develop a novel MMD grading system.
METHODS: In 40 MMD patients bilateral revascularization surgery was performed. Clinical data including DSA, MRI and regional cerebral blood flow studies were assessed. χ(2) test corrected for dependency of measurements at the same subject and analysis of receiver operating characteristics were used to identify key parameters. Grading system included: DSA (stenosis/occlusion = 1 point; stenosis/occlusion + intracranial compensation = 2 points; stenosis/occlusion + intracranial compensation + extra-intracranial compensation = 3 points), MRI (no sign of ischemia = 0 points; signs of ischemia = 1 point) and cerebrovascular reserve capacity (CVRC > -5% = 0 points; CVRC < -5% = 2 points). MMD grade I referred to 1-2 points, grade II to 3-4 and grade III to 5-6 points.
RESULTS: DSA, MRI and CVRC were dependent factors associated with the occurrence of clinical symptoms. Receiver operating characteristics analysis indentified the grading system as superior to each single parameter in predicting clinical symptoms. Fourteen hemispheres were graded as mild (grade I), 35 as moderate (grade II) and 31 as severe (grade III); 21% of grade I, 63% of grade II and 93% of grade III hemispheres were clinically symptomatic.
CONCLUSIONS: The proposed grading system allows to stratify for clinical symptomatology in MMD patients. Future studies will have to investigate its value for assessing clinical symptoms and treatment risks.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21576942     DOI: 10.1159/000326077

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  12 in total

1.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

Review 2.  Heritable and non-heritable uncommon causes of stroke.

Authors:  A Bersano; M Kraemer; A Burlina; M Mancuso; J Finsterer; S Sacco; C Salvarani; L Caputi; H Chabriat; S Lesnik Oberstein; A Federico; E Tournier Lasserve; D Hunt; M Dichgans; M Arnold; S Debette; H S Markus
Journal:  J Neurol       Date:  2020-04-21       Impact factor: 4.849

3.  Hemodynamic contribution of transdural collateral flow in adult patients with moyamoya disease.

Authors:  Ji Man Hong; Yoon Hee Hong; Seong-Joon Lee; Sung Eun Lee; Jin Soo Lee; Dong Hoon Shin
Journal:  Neurol Sci       Date:  2016-09-02       Impact factor: 3.307

4.  Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.

Authors:  Travis R Ladner; Manus J Donahue; Daniel F Arteaga; Carlos C Faraco; Brent A Roach; L Taylor Davis; Lori C Jordan; Michael T Froehler; Megan K Strother
Journal:  J Neurosurg       Date:  2016-03-11       Impact factor: 5.115

5.  Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease.

Authors:  Jian-Jian Zhang; Zhong-Wei Xiong; Sheng Wang; Shou-Jia Sun; Hao Wang; Xiao-Lin Wu; Long Wang; Hua-Qiu Zhang; Chao You; Yu Wang; Jin-Cao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

6.  Hemodynamics and changes after STA-MCA anastomosis in moyamoya disease and atherosclerotic cerebrovascular disease measured by micro-Doppler ultrasonography.

Authors:  Hanako Morisawa; Takakazu Kawamata; Akitsugu Kawashima; Masataka Hayashi; Kohji Yamaguchi; Taku Yoneyama; Yoshikazu Okada
Journal:  Neurosurg Rev       Date:  2012-11-29       Impact factor: 3.042

7.  Current trends in pediatric moyamoya: a survey of international practitioners.

Authors:  Harishchandra Lalgudi Srinivasan; Moran Hausman-Kedem; Edward R Smith; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2021-03-10       Impact factor: 1.475

8.  Surgical Management of Failed Revascularization in Moyamoya Vasculopathy.

Authors:  Kristin Lucia; Güliz Acker; Nicolas Schlinkmann; Stefan Georgiev; Peter Vajkoczy
Journal:  Front Neurol       Date:  2021-06-29       Impact factor: 4.003

9.  Postpartum-Onset Moyamoya Disease: A Rare Cause of Stroke in Unexpected.

Authors:  Muhammet Ozer; Khadija Merchant; Zulfiya Manning; Suleyman Yasin Goksu; Kirti Juneja; Vernard S Fennell
Journal:  Case Rep Neurol Med       Date:  2020-07-15

Review 10.  A critical appraisal of bypass surgery in moyamoya disease.

Authors:  Michael Moussouttas; Igor Rybinnik
Journal:  Ther Adv Neurol Disord       Date:  2020-05-26       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.